Rhen
Yes. I believe ~$12 is fairly priced currently, but a company with the growth rate of MSLP must be revalued frequently reflecting current factors hence my holdings. I have posted my strategy/goals regarding my MSLP holdings. I hold 23,478 shares right this second with 224 on the bid @.94. I am looking to actively sell 5000-7500 shares at ~$13 in escalating intervals.
I do believe the recent PPS appreciation is due to non-significant factors such as Manziel deal and Brad's open market purchases. I do not see any value in those factors thus my desire to sell ~25% of my holdings at what I feel is slightly over-valued levels. $12 assessed value using a 10% range would make me a buyer around $11 (I am) and a seller around $13 (I am) with only ~25% of my holdings. That range would change on a frequent basis based on MSLP growth rate. The historical issue has been the dilution rate has grown at a slightly higher rate than the revenue growth rate but that must be evaluated frequently as well as dilution is expected to decrease going forward.
What I consider significant factors could affect my revaluation. These would include new deals/distribution, SEC finding, NASDAQ uplisting, etc....
I am not convinced any of those are on the near horizon but I could be wrong. There are still plenty of red flags with MSLP but they are thinning out.
Calls for a $20 PPS by year end would be a market cap of $250m with a zero dilution rate. Possible? maybe. Probable? not
I doubt this company deserves a PE of 40 with forecasted 2014 earnings of $.50 share and revenues of $200m.
News 
Market Data 
Discover 
AI
